Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physician's Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer
Clinical trial NCT03755141 · COMPLETED
Trial details
- NCT number
- NCT03755141
- Sponsor
- National Cancer Center, Korea
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-15
- Primary completion
- 2021-08-24
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.